Atropine should never be staed when the patient is cyanosed due to danger of :
**Core Concept:** Atropine is a drug that acts as a competitive antagonist of the muscarinic acetylcholine receptors, primarily affecting the parasympathetic nervous system. It is commonly used to counteract the effects of other drugs like atropine, scopolamine, or beta-blockers, or as part of resuscitation therapy in cardiac arrest. In this question, the focus is on the potential dangers of using atropine in a cyanosed patient.
**Why the Correct Answer is Right:** In a cyanosed patient, the term "cyanosed" refers to the presence of cyanide in the blood due to impaired oxygenation, often seen in poisoning or hypoxia. When atropine is administered to a cyanosed patient, it blocks the parasympathetic activity, leading to decreased heart rate, decreased cardiac output, and decreased oxygen delivery, exacerbating the cyanosis.
**Why Each Wrong Option is Incorrect:**
A. Atropine's action on parasympathetic blockade does not directly address the cyanide poisoning or hypoxia, which is the primary issue in a cyanosed patient.
B. Although atropine may decrease heart rate and cardiac output, in this context, it is counterproductive due to the impaired oxygenation.
C. This option is incorrect as it does not address the core issue of cyanide poisoning or hypoxia.
D. Similar to option B, decreasing cardiac output and heart rate would worsen the cyanosis in a cyanosed patient.
**Clinical Pearl:** In any cyanosed patient, the primary therapy should focus on addressing the underlying cause of cyanide poisoning or hypoxia. Administering atropine can be counterproductive and should be avoided. Instead, consider supportive measures such as oxygen therapy, antidotes (like hydroxocobalamin for cyanide poisoning), or addressing the cause of hypoxia.